Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2476601
rs2476601
0.900 GeneticVariation UNIPROT

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation GWASCAT A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus. 27193031

2017

dbSNP: rs2476601
rs2476601
A 0.900 GeneticVariation GWASCAT A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. 19838195

2009

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE A missense single-nucleotide polymorphism (SNP) within this gene (rs2476601) has recently been associated with 4 autoimmune diseases: rheumatoid arthritis (RA), systemic lupus erythematosus, autoimmune thyroid disease, and type 1 diabetes mellitus, all of which are T cell-mediated and associated with the elaboration of autoantibody. 15934099

2005

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE Among the 26 non-MHC gene alleles analyzed, SNP rs2476601 in PTPN22 gene confers the highest risk for SLE (p = 0.0001; OR = 5.6). 31032751

2019

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE Case-only analysis using lupus-related clinical criteria revealed differences between EA SLE patients positive for moderate to high titers of IgG anti-cardiolipin (aCL IgG >20) versus negative aCL IgG at rs2476601 (P = 0.012, OR = 1.65). 23950893

2013

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. 16868974

2006

dbSNP: rs2476601
rs2476601
A 0.900 GeneticVariation GWASCAT Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. 26502338

2015

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation GWASCAT Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus. 27399966

2016

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation GWASCAT Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases. 30573655

2019

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE In addition, PTPN22 1858 C/T and T/T genotypes were present at a significantly higher frequency in SLE patients than in controls (P = 0.02, OR 1.55 [95% CI 1.05-2.29]). 15641066

2005

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE In conclusion, this meta-analysis confirms that the PTPN22 C1858T polymorphism is associated with SLE susceptibility in different ethnic groups, and that its prevalence is ethnicity dependent. 21078766

2011

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE In observational studies, the associations of 1858 C/T genetic variant were noteworthy for 12 autoimmune or autoimmunity-related diseases (rheumatoid arthritis, systemic lupus erythematosus, type 1 diabetes mellitus, juvenile idiopathic arthritis, Crohn's disease, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, vitiligo, Graves' disease, myasthenia gravis, Addison's disease, giant cell arteritis, and endometriosis). 30871019

2019

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE In summary, PTPN22 rs2476601 was significantly interrelated with SLE and contributed to susceptibility and development of SLE in Americans, Europeans and Africans in this analysis, while their relationship needs to be validated in Africans by future research. 28528372

2017

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE Multiplex family-based study in systemic lupus erythematosus: association between the R620W polymorphism of PTPN22 and the FcgammaRIIa (CD32A) R131 allele. 17092257

2006

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE No association of PTPN22 R620W gene polymorphism with rheumatic heart disease and systemic lupus erythematosus. 21384170

2011

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE Our results confirm an association of the 1858 C>T polymorphism of the PTPN22 gene with SLE, which was previously observed in other populations. 19210878

2009

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE PTPN22 1858C>T gene polymorphism in patients with SLE: association with serological and clinical results. 24985973

2014

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE PTPN22 R620W was associated with GD susceptibility (OR 4.3, p = 0.004), but was not associated with SLE (OR 1.8, p = 0.19). 28500376

2017

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE PTPN22 1858C > T polymorphism and susceptibility to systemic lupus erythematosus: a meta-analysis update. 28990435

2017

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE PTPN22 polymorphisms, but not R620W, were associated with the genetic susceptibility of systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population. 27166176

2016

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus. 26018863

2015

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE Recently a single-nucleotide polymorphism (SNP) 1858 C/T within this gene was shown to be a risk factor for several autoimmune diseases, such as rheumatoid arthritis (RA), Graves' Disease (GD), systemic lupus erythematosus (SLE), Wegener's granulomatosis (WG) and type 1 diabetes mellitus (T1D). 21467606

2011

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE Since the expression of the negative T-cell signaling molecule PTPN22 is increased and a marker of poor prognosis in SLE, we tested the influence of its missense risk allele Trp<sup>620</sup> (rs2476601C>T) on Treg frequency. 31781109

2019

dbSNP: rs2476601
rs2476601
0.900 GeneticVariation BEFREE The R620W SNP was associated with SLE (genotypic P=.00009), with estimated minor (T) allele frequencies of 12.67% in SLE cases and 8.64% in controls. 15273934

2004